Novo Nordisk, Pfizer and other big pharma companies have just taken [the hormone] GLP-1 itself, and spent 20 years stabilising the peptide, making it druggable, so its not broken down [in the body], explains John Unitt, vice president of immunology and inflammation drug discovery at Sygnature Discovery in Nottinghamshire, UK, and a GPCR drug discovery expert
Hopkins, R
Conclusion This study highlights the wide-ranging impacts of GLP-1 receptor agonists on mental health outcomes
Epidemiology of Insomnia: Prevalence, Course, Risk Factors, and Public Health Burden
It also helps remove metabolic byproducts that can interfere with cellular function
Song JH, Fujimoto K, Miyazawa T (2000) Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid-containing oils